Bi H, Wang F, Lin L, Zhang D, Chen M, Shang Y
Virulence. 2025; 16(1):2466482.
PMID: 39950866
PMC: 11834503.
DOI: 10.1080/21505594.2025.2466482.
Izadi N, Solar P, Hasanova K, Zamani A, Akbar M, Mrazova K
Fluids Barriers CNS. 2025; 22(1):3.
PMID: 39780275
PMC: 11708195.
DOI: 10.1186/s12987-025-00618-z.
Brandon K, Frank W, Stroka K
Am J Physiol Cell Physiol. 2024; 327(4):C1073-C1086.
PMID: 39129490
PMC: 11481987.
DOI: 10.1152/ajpcell.00605.2023.
Stamp M, Halwes M, Nisbet D, Collins D
Fluids Barriers CNS. 2023; 20(1):87.
PMID: 38017530
PMC: 10683235.
DOI: 10.1186/s12987-023-00489-2.
Alsabbagh R, Ahmed M, Alqudah M, Hamoudi R, Harati R
Cancers (Basel). 2023; 15(8).
PMID: 37190188
PMC: 10137309.
DOI: 10.3390/cancers15082258.
Development and validation of a nomogram for the prediction of brain metastases in small cell lung cancer.
Li W, Ding C, Sheng W, Wan Q, Cui Z, Qi G
Clin Respir J. 2023; 17(5):456-467.
PMID: 37071990
PMC: 10214575.
DOI: 10.1111/crj.13615.
Overcoming Basal Autophagy, Kangai Injection Enhances Cisplatin Cytotoxicity by Regulating FOXO3a-Dependent Autophagic Cell Death and Apoptosis in Human Lung Adenocarcinoma A549/DDP Cells.
Zhou H, Pan P, Zhao Q, Liu W, Sun Y, Wang J
Biomed Res Int. 2022; 2022:6022981.
PMID: 36093402
PMC: 9458369.
DOI: 10.1155/2022/6022981.
Research on the Mechanism and Prevention of Hypertension Caused by Apatinib Through the RhoA/ROCK Signaling Pathway in a Mouse Model of Gastric Cancer.
Wang W, He Q, Li C, Zhuang C, Zhang H, Wang Q
Front Cardiovasc Med. 2022; 9:873829.
PMID: 35811723
PMC: 9262125.
DOI: 10.3389/fcvm.2022.873829.
Statistical parametrization of cell cytoskeleton reveals lung cancer cytoskeletal phenotype with partial EMT signature.
Basu A, Paul M, Alioscha-Perez M, Grosberg A, Sahli H, Dubinett S
Commun Biol. 2022; 5(1):407.
PMID: 35501466
PMC: 9061773.
DOI: 10.1038/s42003-022-03358-0.
Rho GTPase signalling networks in cancer cell transendothelial migration.
Rodenburg W, van Buul J
Vasc Biol. 2021; 3(1):R77-R95.
PMID: 34738075
PMC: 8558887.
DOI: 10.1530/VB-21-0008.
DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia.
Golla U, Ehudin M, Annageldiyev C, Zeng Z, Tukaramrao D, Tarren A
Cancers (Basel). 2021; 13(19).
PMID: 34638385
PMC: 8508452.
DOI: 10.3390/cancers13194889.
Behind Brain Metastases Formation: Cellular and Molecular Alterations and Blood-Brain Barrier Disruption.
Godinho-Pereira J, Garcia A, Figueira I, Malho R, Brito M
Int J Mol Sci. 2021; 22(13).
PMID: 34209088
PMC: 8268492.
DOI: 10.3390/ijms22137057.
Phenotypic Plasticity Conferred by the Metastatic Microenvironment of the Brain Strengthens the Intracranial Tumorigenicity of Lung Tumor Cells.
Wei X, Bi K, Li B
Front Oncol. 2021; 11:637911.
PMID: 34055607
PMC: 8155524.
DOI: 10.3389/fonc.2021.637911.
Photodynamic Priming Modulates Endothelial Cell-Cell Junction Phenotype for Light-activated Remote Control of Drug Delivery.
Inglut C, Gray K, Vig S, Jung J, Stabile J, Zhang Y
IEEE J Sel Top Quantum Electron. 2021; 27(4).
PMID: 33519171
PMC: 7839980.
DOI: 10.1109/jstqe.2020.3024014.
Salting the Soil: Targeting the Microenvironment of Brain Metastases.
Srinivasan E, Tan A, Anders C, Pendergast A, Sipkins D, Ashley D
Mol Cancer Ther. 2021; 20(3):455-466.
PMID: 33402399
PMC: 8041238.
DOI: 10.1158/1535-7163.MCT-20-0579.
Mechanisms of small cell lung cancer metastasis.
Ko J, Winslow M, Sage J
EMBO Mol Med. 2020; 13(1):e13122.
PMID: 33296145
PMC: 7799359.
DOI: 10.15252/emmm.202013122.
Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage.
Choi K, Nam J, Kim J, Choi S, Lee Y
Exp Mol Med. 2020; 52(5):781-792.
PMID: 32467609
PMC: 7272420.
DOI: 10.1038/s12276-020-0439-4.
Genes that Mediate Metastasis across the Blood-Brain Barrier.
Fares J, Kanojia D, Rashidi A, Ulasov I, Lesniak M
Trends Cancer. 2020; 6(8):660-676.
PMID: 32417182
PMC: 7392815.
DOI: 10.1016/j.trecan.2020.04.007.
Quantitatively relating brain endothelial cell-cell junction phenotype to global and local barrier properties under varied culture conditions via the Junction Analyzer Program.
Gray K, Jung J, Inglut C, Huang H, Stroka K
Fluids Barriers CNS. 2020; 17(1):16.
PMID: 32046757
PMC: 7014765.
DOI: 10.1186/s12987-020-0177-y.
Tumor microenvironment differences between primary tumor and brain metastases.
Cacho-Diaz B, Garcia-Botello D, Wegman-Ostrosky T, Reyes-Soto G, Ortiz-Sanchez E, Herrera-Montalvo L
J Transl Med. 2020; 18(1):1.
PMID: 31900168
PMC: 6941297.
DOI: 10.1186/s12967-019-02189-8.
